Skip to main content

Table 1 KEGG pathway analysis about the differential mRNAs in HER2-positive breast cancer

From: Development of a risk scoring system for evaluating the prognosis of patients with Her2-positive breast cancer

Category

Term

Count

P value

KEGG_PATHWAY

hsa04151:PI3K-Akt signaling pathway

30

7.56E−04

KEGG_PATHWAY

hsa04060:Cytokine-cytokine receptor interaction

24

5.35E−04

KEGG_PATHWAY

hsa05034:Alcoholism

23

1.23E−05

KEGG_PATHWAY

hsa05203:Viral carcinogenesis

20

0.002068396

KEGG_PATHWAY

hsa04510:Focal adhesion

19

0.005049337

KEGG_PATHWAY

hsa04110:Cell cycle

18

3.46E−05

KEGG_PATHWAY

hsa05322:Systemic lupus erythematosus

18

9.40E 05

KEGG_PATHWAY

hsa04114:Oocyte meiosis

16

1.18E− 04

KEGG_PATHWAY

hsa03320:PPAR signaling pathway

14

6.67E−06

KEGG_PATHWAY

hsa04512:ECM-receptor interaction

14

1.20E−04

KEGG_PATHWAY

hsa04152:AMPK signaling pathway

14

0.003364429

KEGG_PATHWAY

hsa04914:Progesterone-mediated oocyte maturation

11

0.005364163

KEGG_PATHWAY

hsa04974:Protein digestion and absorption

11

0.005818118

KEGG_PATHWAY

hsa04610:Complement and coagulation cascades

10

0.003486826

KEGG_PATHWAY

hsa04923:Regulation of lipolysis in adipocytes

9

0.00327098

  1. aIf there were more than five terms enriched in this category, top 15 terms were selected according to count value. Count: the number of enriched mRNAs in each term